Azetukalner

Azetukalner, also known as encukalner and XEN1101, is an experimental small molecule anticonvulsant and selective K v 7.2/K v 7.3 potassium channel opener being investigated as a treatment for refractory focal onset seizures and major…

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Azetukalner, also known as encukalner and XEN1101, is an experimental small molecule anticonvulsant and selective K v 7.2/K v 7.3 potassium channel opener being investigated as a treatment for refractory focal onset seizures and major depressive disorder.

Analogues

Azetukalner is an analogue of flupirtine, retigabine (ezogabine), pynegabine, and fluoxakalner.

See also

List of investigational antidepressants List of investigational bipolar disorder drugs Opakalim

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370307668 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.